Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Why index readings matter: they provide a concise pulse on market health, guiding timely adjustments to risk and allocation.
21,223 articlesA large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Many people chase a $2 million retirement nest egg, but a personalized target matters more. This guide breaks down ho...
Gold has rallied about 73% over the past year as inflation jitters fade and risk-off trades surge. This report shows ...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
A veteran MIT roboticist who cofounded bankrupt robot iRobot cautions that Elon Musk's humanoid vision is not close t...
A BAFTA ceremony moment involving Tourette syndrome sparked a global debate on stigma and language. This report exami...
When an executive sells stock, investors ask whether it signals trouble or simply personal liquidity needs. This guid...
A heartfelt tribute to a TV icon offers more than nostalgia. It can spark practical money moves—funeral budgeting, es...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
A new tax break for Americans 65 and older could reshape retirement budgets. This article unpacks the good, the bad, ...
Rumors around PayPal buyouts grab headlines and move markets. Here’s how to separate signal from noise, evaluate pote...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...